Skip to main content
Earnings Labs
ACADIA Pharmaceuticals Inc. logo

ACADIA Pharmaceuticals Inc. (ACAD)

NASDAQ·Healthcare·Biotechnology

$26.12

+1.99%

Mkt Cap $4.51B

Analyst Ratings

Buy

13

Hold

2

Sell

0

Price Target (63 analysts)

$34.33

Range $29.00$37.00

Implied Upside

+31.4%

Consensus $34.33 vs current $26.12